High Transplant Rates of Highly Sensitized Recipients With Virtual Crossmatching in Kidney Paired Donation

Background In kidney paired donation (KPD), flexibility in the allocation of incompatible pairs is required if a critical mass of pairs to efficiently find matches cannot be reached. Methods In the Australian KPD program, virtual crossmatch is used for the allocation of suitable donors to registered recipients. Matching is based on acceptable mismatches, and donors are excluded from matching to recipients with donor-specific antibodies (DSAs) greater than 2000 mean fluorescence intensity (MFI). Match and transplant rates in the first year of the program were reviewed with respect to recipient and donor characteristics, including blood group distribution, level of recipient’s sensitization, and postallocation crossmatches. Results Four quarterly match runs were performed, which included 53 pairs and 2 altruistic donors. Human leukocyte antigen incompatibility accounted for 90% of the listed pairs. In the second run, the DSA threshold was increased to greater than 8000 MFI, because no matches were found with standard allocation. Optional ABO-incompatible matching was introduced from run 3. Matches were identified in 37 (70%) patients, of whom 92% had a negative crossmatch with their matched donor. Crossmatch positive results were found only in recipients with DSAs greater than 2000 MFI in the second run. In 4 cases immunological reasons and in 4 cases other reasons resulted in breakdown of chains and 17 patients not progressing to transplantation. Eventually, 20 (38%) patients received a KPD transplant, and 35% of these had a calculated panel-reactive antibody greater than 90%. Conclusions KPD using virtual crossmatch is a valid and effective solution for patients with immunologically incompatible donors even in the context of highly sensitized recipients.

[1]  Nathan T. James,et al.  Outcomes of ABO-Incompatible Kidney Transplantation in the United States , 2012, Transplantation.

[2]  J. Boletis,et al.  Long‐term follow up for anti‐HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  D. Rigal,et al.  Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome. , 2011, Transplantation proceedings.

[4]  A. Ender,et al.  HLA Antibody Specification Using Single-Antigen Beads—A Technical Solution for the Prozone Effect , 2011, Transplantation.

[5]  G. Opelz,et al.  Deleterious Impact of Mismatching for Human Leukocyte Antigen-C in Presensitized Recipients of Kidney Transplants , 2011, Transplantation.

[6]  L. Kucirka,et al.  Desensitization in HLA-incompatible kidney recipients and survival. , 2011, The New England journal of medicine.

[7]  R. Walker,et al.  Successful ABO‐Incompatible Kidney Transplantation with Antibody Removal and Standard Immunosuppression , 2011, American Journal of Transplantation.

[8]  F. Christiansen,et al.  Virtual Crossmatch Approach to Maximize Matching in Paired Kidney Donation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  A. Bingaman,et al.  Kidney paired donation in live-donor kidney transplantation. , 2010, The New England journal of medicine.

[10]  Dominique Charron,et al.  Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.

[11]  M. Stegall,et al.  Sensitized renal transplant recipients: current protocols and future directions , 2010, Nature Reviews Nephrology.

[12]  M. de Klerk,et al.  Altruistic Donor Triggered Domino‐Paired Kidney Donation for Unsuccessful Couples from the Kidney‐Exchange Program , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  T. Mohanakumar,et al.  Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation. , 2010, Human immunology.

[14]  Paolo Ferrari,et al.  Paired kidney donations to expand the living donor pool: the Western Australian experience , 2009, The Medical journal of Australia.

[15]  J. Bradley,et al.  Detection of Immunoglobulin G Human Leukocyte Antigen-Specific Alloantibodies in Renal Transplant Patients Using Single-Antigen-Beads is Compromised by the Presence of Immunoglobulin M Human Leukocyte Antigen-Specific Alloantibodies , 2009, Transplantation.

[16]  Rachel J. Johnson,et al.  Early Experience of Paired Living Kidney Donation in the United Kingdom , 2008, Transplantation.

[17]  Frans H J Claas,et al.  Hurdles, Barriers, and Successes of a National Living Donor Kidney Exchange Program , 2008, Transplantation.

[18]  F. Delmonico,et al.  The Development of a Successful Multiregional Kidney Paired Donation Program , 2008, Transplantation.

[19]  L. Kavoussi,et al.  Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. , 2005, JAMA.

[20]  F. Claas,et al.  The Dutch National Living Donor Kidney Exchange Program , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.